This proposal is directed at the design and development of general synthetic methodology and the application of this methodology to the synthesis of the potent tumor promoters and inhibitors of the tigliane, ingenane, and daphnane families. These efforts and supporting structure activity studies are intended to establish new chemistry and to contribute to our understanding of tumor promotion, a potentially significant factor in the multifactorial etiology of human cancer. The syntheses of the targets and their analogues are to be realized through the use of a divinylcyclopropane strategy, an intramolecular Diels-Alder strategy, and an intramolecular arene olefin cycloaddition strategy. The viability of intramolecular [6 + 4] and [5 + 2] cycloadditions for the elaboration of the target skeleta are also proposed. Degradation and partial syntheses are proposed to support these synthesis studies and to provide analogues for structure activity investigations. The latter effort will be conducted, in part, using computer modelling. These studies are intended to contribute to our understanding of tumor promotion, its role in cancer, and how it can be suppressed or inhibited. A synthesis of the anti-leukemic agent quadrone is also proposed based on the intramolecular arene olefin cycloaddition, a fundamentally new methodology for total synthesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA031841-05
Application #
3169946
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1981-07-01
Project End
1988-05-31
Budget Start
1985-06-01
Budget End
1986-05-31
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Arts and Sciences
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
McKinlay, Colin J; Benner, Nancy L; Haabeth, Ole A et al. (2018) Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters. Proc Natl Acad Sci U S A 115:E5859-E5866
Haabeth, Ole A W; Blake, Timothy R; McKinlay, Colin J et al. (2018) mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice. Proc Natl Acad Sci U S A 115:E9153-E9161
Khan, Tapan K; Wender, Paul A; Alkon, Daniel L (2018) Bryostatin and its synthetic analog, picolog rescue dermal fibroblasts from prolonged stress and contribute to survival and rejuvenation of human skin equivalents. J Cell Physiol 233:1523-1534
Marsden, Matthew D; Wu, Xiaomeng; Navab, Sara M et al. (2018) Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents. Virology 520:83-93
Ryckbosch, Steven M; Wender, Paul A; Pande, Vijay S (2017) Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes. Nat Commun 8:6
McKinlay, Colin J; Vargas, Jessica R; Blake, Timothy R et al. (2017) Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals. Proc Natl Acad Sci U S A 114:E448-E456
Benner, Nancy L; Zang, Xiaoyu; Buehler, Daniel C et al. (2017) Vault Nanoparticles: Chemical Modifications for Imaging and Enhanced Delivery. ACS Nano 11:872-881
Staveness, Daryl; Abdelnabi, Rana; Near, Katherine E et al. (2016) Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway. J Nat Prod 79:680-4
Pavlovic, Igor; Thakor, Divyeshsinh T; Vargas, Jessica R et al. (2016) Cellular delivery and photochemical release of a caged inositol-pyrophosphate induces PH-domain translocation in cellulo. Nat Commun 7:10622
Hsu, Hsiao-Tieh; Trantow, Brian M; Waymouth, Robert M et al. (2016) Bioorthogonal Catalysis: A General Method To Evaluate Metal-Catalyzed Reactions in Real Time in Living Systems Using a Cellular Luciferase Reporter System. Bioconjug Chem 27:376-82

Showing the most recent 10 out of 75 publications